Name | Enibarcimab |
---|
Description | Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID 2019 infections and septic shock research[1]. |
---|---|
Related Catalog | |
Target |
Immunoglobulin G1[1] |
References |
No Any Chemical & Physical Properties |